- Home
- NKGN vs SCNX Comparison
NKGN vs SCNX Comparison
Compare NKGN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKGN
- SCNX
- Stock Information
- Founded
- NKGN 2017
- SCNX 2010
- Country
- NKGN United States
- SCNX United States
- Employees
- NKGN N/A
- SCNX N/A
- Industry
- NKGN Biotechnology: Biological Products (No Diagnostic Substances)
- SCNX Other Pharmaceuticals
- Sector
- NKGN Health Care
- SCNX Health Care
- Exchange
- NKGN Nasdaq
- SCNX Nasdaq
- Market Cap
- NKGN 14.1M
- SCNX 13.1M
- IPO Year
- NKGN N/A
- SCNX 2020
- Fundamental
- Price
- NKGN $0.28
- SCNX $7.24
- Analyst Decision
- NKGN
- SCNX
- Analyst Count
- NKGN 0
- SCNX 0
- Target Price
- NKGN N/A
- SCNX N/A
- AVG Volume (30 Days)
- NKGN 360.3K
- SCNX 12.0K
- Earning Date
- NKGN 11-12-2024
- SCNX 08-09-2024
- Dividend Yield
- NKGN N/A
- SCNX N/A
- EPS Growth
- NKGN N/A
- SCNX N/A
- EPS
- NKGN N/A
- SCNX N/A
- Revenue
- NKGN N/A
- SCNX N/A
- Revenue This Year
- NKGN N/A
- SCNX $14.67
- Revenue Next Year
- NKGN N/A
- SCNX N/A
- P/E Ratio
- NKGN N/A
- SCNX N/A
- Revenue Growth
- NKGN N/A
- SCNX N/A
- 52 Week Low
- NKGN $0.27
- SCNX $3.69
- 52 Week High
- NKGN $5.10
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- NKGN 23.41
- SCNX N/A
- Support Level
- NKGN $0.36
- SCNX N/A
- Resistance Level
- NKGN $0.44
- SCNX N/A
- Average True Range (ATR)
- NKGN 0.04
- SCNX 0.00
- MACD
- NKGN 0.00
- SCNX 0.00
- Stochastic Oscillator
- NKGN 5.04
- SCNX 0.00
About NKGN NKGen Biotech Inc.
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.